Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

25 May 2017 07:00

RNS Number : 1609G
Huntsworth PLC
25 May 2017
 

 

Huntsworth

Trading update

 

Huntsworth plc, the healthcare communications and public relations group, is today issuing the following trading update for the four months to 30 April 2017.

 

· Group's full year results to be ahead of current consensus

· Strong trading at Huntsworth Health and Red

· Grayling trading in line with management expectations helped by UK agency returning to profit

 

Trading

 

The Group traded well through the first four months of the year, led again by strong growth at Huntsworth Health. On a like for like basis Huntsworth Health's revenues increased by over 10%, with good margin performance despite ongoing investment in talent and further diversification in two of the agencies. All of Huntsworth Health's main agencies grew in the period, led by the two largest - Evoke and Apothecom - which together account for circa 80% of divisional revenue.

 

Grayling's UK business returned to profitability in the period which means that, together with its European businesses, a large part of Grayling (representing circa 70% of annual divisional revenues) is now profitable. The US and META regions, however, remain challenging. Although we expect a decline in Grayling's like for like revenues this year, the division is trading in line with management's expectations.

 

Red has performed strongly in the period with revenues up by over 10%, with a number of new client wins. Some client churn is expected in the second half of the year which will dampen the overall annual growth rate.

 

Citigate Dewe Rogerson has experienced a mixed trading period with revenues down 2% on a like for like basis. Operations in the Netherlands, Singapore and Hong Kong have performed well, but slower transactional markets in the UK and mainland China have impacted overall revenue growth and profitability and will likely weigh on the business further during the year.

 

 

Financial Position

 

The Group remains in a strong financial position, operating well within its £70m facility. Net debt at 19 May 2017 was c. £31m, in line with management expectations.

 

 

Outlook

 

As a result of the stronger growth at Health and Red along with improved prospects at Grayling, we now expect the Group's full year results to be ahead of current consensus*.

 

The Group remains focused on driving operating profit by concentrating resources on its faster growing agencies and actively managing those underperforming ones. The Board is confident of continued progress through the remainder of 2017.

 

 

*Midpoint of consensus range for Headline PBT is £19.3m

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Georgia Colkin

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGPAUPMGQC
Date   Source Headline
18th Nov 20117:00 amRNSInterim Management Statement
11th Nov 20113:24 pmRNSAdditional Listing
11th Nov 20113:17 pmRNSDirector/PDMR Shareholding
1st Nov 20114:26 pmRNSTotal Voting Rights
1st Nov 20117:00 amRNSTransaction in Own Shares
31st Oct 20117:00 amRNSTransaction in Own Shares
28th Oct 20117:00 amRNSTransaction in Own Shares
20th Oct 20117:00 amRNSTransaction in Own Shares
19th Oct 20117:58 amRNSTransaction in Own Shares
12th Oct 20112:43 pmRNSScrip Dividend Alternative
7th Oct 20113:55 pmRNSDirector/PDMR Shareholding
6th Oct 20117:00 amRNSTransaction in Own Shares
5th Oct 20117:00 amRNSTransaction in Own Shares
4th Oct 20117:00 amRNSTransaction in Own Shares
3rd Oct 20112:05 pmRNSTotal Voting Rights
27th Sep 20117:00 amRNSTransaction in Own Shares
22nd Sep 20117:00 amRNSTransaction in Own Shares
21st Sep 20117:00 amRNSTransaction in Own Shares
20th Sep 20114:05 pmRNSDirector/PDMR Shareholding
15th Sep 201110:04 amRNSDirector/PDMR Shareholding
15th Sep 20117:00 amRNSTransaction in Own Shares
12th Sep 201112:00 pmRNSTransaction in Own Shares
8th Sep 20119:21 amRNSDirector/PDMR Shareholding
8th Sep 20117:00 amRNSTransaction in Own Shares
6th Sep 20119:45 amRNSTransaction in Own Shares
5th Sep 20117:00 amRNSTransaction in Own Shares
2nd Sep 20119:28 amRNSTotal Voting Rights
2nd Sep 20119:13 amRNSDirector/PDMR Shareholding
2nd Sep 20119:12 amRNSDirector/PDMR Shareholding
2nd Sep 20117:00 amRNSTransaction in Own Shares
31st Aug 20112:20 pmRNSDirector/PDMR Shareholding
31st Aug 201110:33 amRNSTransaction in Own Shares - Amendment
31st Aug 20117:00 amRNSTransaction in Own Shares
30th Aug 20119:06 amRNSShare Buy-back Programme
25th Aug 20117:00 amRNSInterim Results
3rd Aug 20117:00 amRNSNotice of Interim Results
1st Aug 201110:25 amRNSTotal Voting Rights
21st Jul 20117:00 amRNSTransaction in Own Shares
20th Jul 20117:00 amRNSTransaction in Own Shares
19th Jul 20115:25 pmRNSDirector's Other Directorships
19th Jul 20117:00 amRNSTransaction in Own Shares
18th Jul 20117:00 amRNSTransaction in Own Shares
7th Jul 201111:42 amRNSDirector/PDMR Shareholding
4th Jul 20113:04 pmRNSAdditional Listing
4th Jul 20117:00 amRNSTransaction in Own Shares
1st Jul 201112:17 pmRNSTotal Voting Rights
30th Jun 20117:00 amRNSShare Buy-Back Programme
29th Jun 20117:00 amRNSTransaction in Own Shares
24th Jun 20117:00 amRNSTransaction in Own Shares
23rd Jun 20117:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.